Mineralys Therapeutics (MLYS) Insider Trading & Ownership $11.27 +0.13 (+1.17%) (As of 08/22/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Mineralys Therapeutics (NASDAQ:MLYS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage33.24%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$7.55 MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$9.21 M Get MLYS Insider Trade Alerts Want to know when executives and insiders are buying or selling Mineralys Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MLYS Insider Buying and Selling by Quarter Ad AltimetryAI Caught “Red-Handed” Attempting Insider TradeSay Hello to The New Market Aristocrats: A special type of investing has now overtaken the stock market. And it's creating a new class of millionaire and billionaire "aristocrats": From former hippies and Cold War codebreakers... to the owner of the Boston Red Sox. One "Market Aristocrat" breaks his silence — and reveals a massive new investing opportunity.Click here now to hear his shocking revelation. Mineralys Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/24/2024Brian Taylor SlingsbyDirectorSell550,000$13.05$7,177,500.00 7/16/2024David Malcom RodmanInsiderSell525$15.00$7,875.00 7/11/2024Adam Scott LevyCFOSell10,757$13.14$141,346.98 7/11/2024Jon CongletonCEOSell15,746$13.34$210,051.64 6/14/2024Jon CongletonCEOSell16,229$12.52$203,187.08 6/12/2024Jon CongletonCEOSell16,607$12.77$212,071.39 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/11/2024Adam Scott LevyCFOSell96,815$12.94$1,252,786.10 5/9/2024David Malcom RodmanInsiderSell100$15.00$1,500.00 2/12/2024Samsara Biocapital Gp, LlcMajor ShareholderBuy555,555$13.50$7,499,992.50 11/22/2023Jon CongletonCEOBuy4,250$5.97$25,372.50 9/6/2023Jon CongletonCEOBuy2,250$12.08$27,180.00 (Data available from 1/1/2013 forward) MLYS Insider Trading Activity - Frequently Asked Questions Who is on Mineralys Therapeutics's Insider Roster? The list of insiders at Mineralys Therapeutics includes Adam Scott Levy, Brian Taylor Slingsby, David Malcom Rodman, Hbm Healthcare Investments (Ca, Jon Congleton, Ra Capital Management, L.P., and Samsara Biocapital Gp, Llc. Learn more on insiders at MLYS. What percentage of Mineralys Therapeutics stock is owned by insiders? 33.24% of Mineralys Therapeutics stock is owned by insiders. Learn more on MLYS's insider holdings. Which Mineralys Therapeutics insiders have been buying company stock? The following insiders have purchased MLYS shares in the last 24 months: Adam Scott Levy ($100,000.00), Hbm Healthcare Investments (Ca ($5,000,000.00), Jon Congleton ($105,557.50), Ra Capital Management, L.P. ($20,000,000.00), and Samsara Biocapital Gp, Llc ($7,499,992.50). How much insider buying is happening at Mineralys Therapeutics? Insiders have purchased a total of 2,135,055 MLYS shares in the last 24 months for a total of $32,705,550.00 bought. Which Mineralys Therapeutics insiders have been selling company stock? The following insiders have sold MLYS shares in the last 24 months: Adam Scott Levy ($1,394,133.08), Brian Taylor Slingsby ($7,177,500.00), David Malcom Rodman ($2,021,710.71), and Jon Congleton ($625,310.11). How much insider selling is happening at Mineralys Therapeutics? Insiders have sold a total of 863,870 Mineralys Therapeutics shares in the last 24 months for a total of $11,218,653.90 sold. More Insider Trading Tools from MarketBeat Related Companies: CPRX Insider Buying VRNA Insider Buying AMPH Insider Buying MRVI Insider Buying VERA Insider Buying HRMY Insider Buying BHC Insider Buying JANX Insider Buying MIRM Insider Buying LGND Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Small Cap Stocks Insiders Are Actively BuyingTop 2 High-Yield Stocks That Insiders Are BuyingInsider Selling: When It Matters and When It Doesn'tInsiders Sell These Tech Stocks, but Investors Shouldn’tWhat Does Market Rotation Mean for This Top AI Stock? This page (NASDAQ:MLYS) was last updated on 8/23/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredDid Wall St. Buy Your Stocks for A Discount Last Week?New Wave of "Pre-Programmed" Stock Crashes: Like landmines, a wave of crashes just rocked the stock market....Altimetry | Sponsored44-year Wall Street Vet: “Irreversible destruction is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredDaily Options Pick (Delivered)I'm going to send you my best options pick every single morning for 100% free. Why should you listen to me?...Prosper Trading Academy | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mineralys Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.